This inventor holds 1 USPTO granted patent. Top assignee: Scinopharm Taiwan, Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Yong Mu - Innovator in Pharmaceutical Chemistry
Introduction
Yong Mu is a distinguished inventor based in Changshu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds used in medical treatments. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing healthcare solutions.
Latest Patents
Yong Mu holds a patent for a process and intermediates for preparing lapatinib. This compound, represented by the formula (X), serves as an intermediate in the synthesis of lapatinib or its pharmaceutically acceptable salt. This invention is crucial for the production of effective treatments for various medical conditions.
Career Highlights
Yong Mu is currently employed at Scinopharm Taiwan, Ltd., where he continues to push the boundaries of pharmaceutical research. His work at this company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to innovative drug development.
Collaborations
Yong Mu has worked alongside notable colleagues, including Yung-Fa Chen and Julian Paul Henschke. These collaborations have fostered a dynamic environment for research and innovation, leading to advancements in pharmaceutical chemistry.
Conclusion
Yong Mu's contributions to the field of pharmaceutical chemistry, particularly through his patent for lapatinib, highlight his role as an influential inventor. His ongoing work at Scinopharm Taiwan, Ltd. and collaborations with esteemed colleagues underscore his commitment to improving healthcare through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile